Q1 2026 Psychedelic Patent Update

Written by Psychedelic Alpha’s Noah Smith with support from Editor-at-Large and patent attorney Graham Pechenik of Calyx Law.

The Psychedelic Patent Update provides headline figures and data regarding published psychedelic patent applications and grants, as well as a brief analysis.

A Look Back At 2025

Since November 2023, we've been tracking prosecution status updates for every U.S. patent application in our database, giving us an increasingly granular view of how the psychedelic IP landscape is evolving in real time.

Today, that database spans nearly 1,500 U.S. patents and applications and over 1,000 PCT filings, covering not just classic psychedelics but the rapidly growing domain of ‘neuroplastogens.’

Before diving into trends from the first quarter of 2026, it's worth taking stock of what happened last year.

Notably, we added 156 PCTs and 271 U.S. relevant patent applications to our tracker throughout 2025. Further, companies operating in the space saw 122 of their U.S. patents issued over the same period.

In 2025, we added 271 new U.S. patent publications and 156 PCTs to our tracker. Meanwhile, 122 U.S. patents issued to companies operating in the space. CaaMTech, GH Research, Gilgamesh, Atai/Beckley, and Compass Pathways were among the most active filers, each with more than a dozen new...